Work

CRISPR/Cas9-Mediated Protection of Normal Hematopoiesis Combined with the CD33/CD3 Bispecific T-Cell Engager (BiTE) Antibody AMG330 for Improved AML Therapy

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-129399

Authors: Olivier Humbert, Mallory J Llewellyn, George S. Laszlo, Roland B. Walter, Hans-Peter Kiem

Institutions: Fred Hutch Cancer Center, University of Washington

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2983093812

Cites:

Cited by: 1

Related to: 10